Copyright © Inderes 2011 - present. All rights reserved.
  • Uusimmat
  • Pörssi
    • Aamukatsaus
    • Osakevertailu
    • Pörssikalenteri
    • Osinkokalenteri
    • Analyysi
    • Artikkelit
    • Sisäpiirin kaupat
  • inderesTV
  • Mallisalkku
  • Foorumi
  • Premium
  • Femme
  • Opi
    • Sijoituskoulu
    • Q&A
    • Analyysikoulu
  • Meistä
    • Seurantayhtiöt
    • Tiimi
Pörssitiedote

NOTICE OF EXTRAORDINARY GENERAL MEETING OF SCANDINAVIAN REAL HEART AB

Scandinavian Real Heart
Lataa tiedote

The shareholders of Scandinavian Real Heart AB, org.nr. 556729-5588 (the "Company"), are hereby invited to attend the Extraordinary General Meeting to be held on Tuesday, November 24, 2025 at 5:30 p.m. at Best Western Plus Hotel Plaza, Kopparbergsvägen 10, 722 13 Västerås, Sweden. Registration for the meeting will commence at 5:00 p.m.

Right to participate in the meeting, etc.

Shareholders who wish to participate in the Meeting must:

  • be entered in the share register maintained by Euroclear Sweden AB no later than Monday 17 November 2025, and
  • notify the Company of their intention to participate no later than Wednesday 19 November 2025 by mail to Scandinavian Real Heart AB, attn: Jimmy Nybom, Kopparbergsvägen 6, 722 13 Västerås or by e-mail to jimmy.nybom@realheart.se. The notification must state the full name, personal identity number or corporate registration number, shareholding, address, daytime telephone number and, where applicable, information about the deputies or assistants (maximum two).

In order to be entitled to participate in the meeting, a shareholder whose shares are registered in the name of a nominee must, in addition to giving notice of participation in the meeting, register the shares in their own name so that the shareholder is included in the presentation of the share register as of the record date of Monday, November 17, 2025. Such re-registration may be temporary (so-called voting rights registration) and is requested from the nominee in accordance with the nominee's procedures at such time in advance as determined by the nominee. Voting rights registration made by the nominee no later than Wednesday, November 19, 2025 will be taken into account in the preparation of the general meeting share register.

Agents, etc.

If a shareholder is to be represented by a proxy, the proxy must bring a written, dated and signed power of attorney to the meeting. The power of attorney may not be older than one year unless it specifies that it is valid for a longer period of time, but not more than five years. If the power of attorney has been issued by a legal entity, the representative must also bring the current certificate of registration or equivalent authorization document for the legal entity. To facilitate entry, a copy of the power of attorney and other authorization documents should be attached to the notification to the meeting. Proxy forms are available on the Company's website www.realheart.se and will be sent by mail to shareholders who contact the Company and state their address.

Processing of personal data

For information on how personal data is processed in connection with the Annual General Meeting, please refer to the privacy policy available on Euroclear Sweden AB's website: https://www.euroclear.com/dam/ESw/Legal/Integritetspolicy-bolagsstammor-svenska.pdf.

Draft agenda

  1. Election of Chairman of the Meeting
  2. Election of minutes of the meeting
  3. Election of one or two persons to verify the minutes
  4. Preparation and approval of the voting list
  5. Approval of the agenda
  6. Determination of whether the meeting has been duly convened
  7. Resolution on new issue of shares
  8. Resolution to amend the Articles of Association
  9. Closing of the meeting

Item 1 – Election of Chairman of the Meeting

The Board of Directors proposes that Jimmy Nybom be elected Chairman of the Meeting.

Item 7 – Resolution on new issue of shares

The Board of Directors' proposal for a resolution on a new issue of shares, appendix 1

Item 8 – Resolution to amend the Articles of Association

The Board of Directors' proposal for a resolution to amend the Articles of Association, appendix 2

The proposed Articles of Association in its entirety, appendix 3

The resolution is conditional upon the Annual General Meeting resolving in accordance with item 7 of the notice.

Majority requirements

A valid resolution under resolution item 8 requires that the proposals are supported by shareholders representing at least two-thirds of both the votes cast and the shares represented at the meeting.

Information on the number of shares and votes

At the time of issuing this notice, the total number of shares and votes in the Company amounts to 4,998,704.

Shareholders' right to receive information

Shareholders are reminded of the right to request information from the Board of Directors and the CEO at the Annual General Meeting in accordance with Chapter 7. Section 32 of the Swedish Companies Act (2005:551).

Provision of documents

Documents in accordance with the Swedish Companies Act will be available at the Company's office no later than two weeks prior to the Annual General Meeting and will be sent free of charge to the shareholder who so requests and states their postal address. The documents will also be available on the Company's website www.realheart.se at the latest from this date. All of the above documents will also be presented at the Annual General Meeting.

Västerås in October 2025

Scandinavian Real Heart

The Board of Directors

For more information, please contact:
Ina Laura Perkins, CEO
Phone: +46 (0) 70 406 49 21 
E-mail: inalaura.perkins@realheart.se
Certified Adviser: Svensk Kapitalmarknadsgranskning AB, www.skmg.se

About Us
Scandinavian Real Heart AB (publ) is developing the first artificial heart that mimics the shape, function, and blood flow pattern of the human heart. These unique product features provide completely new opportunities to save lives and give patients a good quality of life while waiting for a heart transplant. In the future, artificial hearts may also become an alternative to transplantation for broader groups of patients with severe heart failure. Realheart® TAH (Total Artificial Heart) is now being evaluated in extensive preclinical trials ahead of a first clinical study in patients. The company's shares are traded on Nasdaq Stockholm First North Growth Market. For more information, visit www.realheart.se

This information is information that Scandinavian Real Heart is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-10-24 17:50 CEST.

Attachments
NOTICE OF EXTRAORDINARY GENERAL MEETING OF SCANDINAVIAN REAL HEART AB
Board Resolution On Rights Issue
Board Resolution On Change Of Articles Of Association
Articles Of Association

Sosiaalinen media
  • Inderes Foorumi
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Yhteystiedot
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • Meistä
  • Tiimi
  • Avoimet työpaikat
  • Inderes sijoituskohteena
  • Palvelut pörssiyhtiöille
Sivusto
  • UKK
  • Käyttöehdot
  • Tietosuojaseloste
  • Vastuuvapauslauseke
Inderesin vastuuvapauslauseke löytyy täältä. Kunkin Inderesin aktiivisessa seurannassa olevan osakkeen tarkemmat tiedot löytyvät kunkin osakkeen omilta yhtiösivuilta Inderes-sivustolla. © Inderes Oyj. Kaikki oikeudet pidätetään.